This is not correct. Both Braf AND RTC/RET mutations lead to Thyroid Papillary carcinoma.
“The papillary thyroid carcinoma oncogene (RET/PTC) is a rearranged version of the tyrosine kinase RET, the receptor for glial-cell-line-derived neurotrophic factor. 13 RET/PTC rearrangement is nearly restricted to papillary thyroid carcinomas”
The extra section even says as much.
Sounds Good…